Meyer T, Jahn N, Lindner S, Rohner L, Dolnik A, Weber D
Leukemia. 2019; 34(2):404-415.
PMID: 31576005
PMC: 7214237.
DOI: 10.1038/s41375-019-0578-6.
Phillips P, Vedig A, Jones P, Chapman M, Collins M, EDWARDS J
Br J Clin Pharmacol. 1980; 9(5):483-91.
PMID: 6104976
PMC: 1429961.
DOI: 10.1111/j.1365-2125.1980.tb05844.x.
Weber M, Stokes G, Gain J
J Clin Invest. 1974; 54(6):1413-9.
PMID: 4154950
PMC: 301696.
DOI: 10.1172/JCI107888.
Attman P, Aurell M, Johnsson G
Eur J Clin Pharmacol. 1975; 8(3-4):201-4.
PMID: 1233219
DOI: 10.1007/BF00567115.
Lancaster R, Goodwin T, Peart W
Br J Clin Pharmacol. 1976; 3(3):453-60.
PMID: 973972
PMC: 2958755.
DOI: 10.1111/j.1365-2125.1976.tb00621.x.
Mechanism of the interaction of propranolol and a potent vasodilator antihypertensive agent - minoxidil.
OMalley K, Velasco M, Wells J, McNay J
Eur J Clin Pharmacol. 1976; 09(5-6):355-60.
PMID: 971700
DOI: 10.1007/BF00606548.
Effect of beta-adrenergic blockade on blood pressure variation in patients with moderate hypertension.
Clement D, Bogaert M, PANNIER R
Eur J Clin Pharmacol. 1977; 11(5):325-7.
PMID: 880971
DOI: 10.1007/BF00566528.
The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise.
Lijnen P, Amery A, Fagard R, Reybrouck T, Moerman E, De Schaepdryver A
Br J Clin Pharmacol. 1979; 7(2):175-81.
PMID: 760750
PMC: 1429426.
DOI: 10.1111/j.1365-2125.1979.tb00918.x.
Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.
Fitzgerald J, Ruffin R, Smedstad K, Roberts R, Mcainsh J
Eur J Clin Pharmacol. 1978; 13(2):81-9.
PMID: 658112
DOI: 10.1007/BF00609750.
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. II. Effect of submaximal work and insulin-induced hypoglycaemia on plasma catecholamines and renin activity, blood pressure and pulse rate.
Hansson B, DYMLING J, Manhem P, HOKFELT B
Eur J Clin Pharmacol. 1977; 11(4):247-54.
PMID: 324772
DOI: 10.1007/BF00607672.
Long term treatment of moderate hypertension with the beta1-receptor blocking agent metoprolol. I. Effect on maximal working capacity, plasma catecholamines and renin, Urinary aldosterone, blood pressure and pulse rate under basal conditions.
Hansson B, DYMLING J, Hedeland H, Hulthen U
Eur J Clin Pharmacol. 1977; 11(4):239-45.
PMID: 324771
DOI: 10.1007/BF00607671.
Controlled study of atenolol in treatment of hypertension.
Hansson L, Aberg H, Karlberg B, Westerlund A
Br Med J. 1975; 2(5967):367-70.
PMID: 236810
PMC: 1673197.
DOI: 10.1136/bmj.2.5967.367.
Effects of salbutamol and metoprolol on plasma renin activity and plasma potassium of normal subjects and of hypertensive patients.
Salvetti A, Poli L, Arzilli F, Sassano L, Pedrinelli R, Motolese M
J Endocrinol Invest. 1978; 1(1):1-8.
PMID: 226572
DOI: 10.1007/BF03346764.
Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
Heel R, Brogden R, Speight T, Avery G
Drugs. 1979; 17(6):425-60.
PMID: 38096
DOI: 10.2165/00003495-197917060-00001.
Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.
Gavras I, Gavras H, Brunner H, Liang C
Br J Clin Pharmacol. 1979; 7 Suppl 2:213S-217S.
PMID: 37876
PMC: 1429320.
Evidence for the participation of beta1-adrenoceptors in isoprenaline-induced renin release from rat kidny slices in vitro.
Desaulles E, Miesch F, Schwartz J
Br J Pharmacol. 1978; 63(3):421-5.
PMID: 27279
PMC: 1668094.
DOI: 10.1111/j.1476-5381.1978.tb07793.x.
Hypertension: which beta-blocker?.
Drugs. 1976; 12(6):412-14.
PMID: 11985
DOI: 10.2165/00003495-197612060-00002.
